{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:18:17Z","timestamp":1791865097138,"version":"4.3.4"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"publisher","award":["Publication fee"],"award-info":[{"award-number":["Publication fee"]}],"id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Within the past 10 years, immune mechanisms associated with acute ischemic stroke (AIS) have been brought into focus, but data on B cell activation and intrathecal Ig production is still scarce. In this study, we determined the prevalence of an elevated IgG index, positive oligoclonal bands (OCBs) and chemokine C-X-C motif ligand 13 (CXCL13) levels in the cerebrospinal fluid (CSF) as markers of intrathecal IgG synthesis and B cell activation in patients with AIS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In a retrospective study we analyzed the cerebrospinal fluid (CSF) from 212 patients with AIS from December 2013 to May 2018 assessing intrathecal Ig synthesis, OCBs and CXCL13 concentrations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Overall, 5.7% (12\/212) of AIS patients showed an intrathecal IgG synthesis, 0.5% (1\/212) with isolated elevated IgG index, 5.2% (7\/136) isolated positive OCBs and 2.9% (4\/136) both elevated IgG index and positive OCBs. CXCL13 levels were elevated in 3.6% (3\/83) of the patients. Approximately one third of these patients had simultaneously chronic inflammatory CNS disease (multiple sclerosis, neuromyelitis optica spectrum disorder, neurosarcoidosis). There was no significant association between CSF findings and stroke characteristics including vascular territory, localization, volume, etiology, acute treatment, or blood-brain barrier dysfunction. Intrathecal IgG synthesis was more common in patients with prior stroke. Longitudinal CSF analysis did not reveal any newly-occurring, but instead mostly persistent or even disappearing intrathecal IgG synthesis after AIS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We found no evidence of a relevant B cell recruitment and intrathecal IgG synthesis in patients with AIS. In fact, the occurrence of intrathecal IgG synthesis was associated with concurrent chronic inflammatory CNS disease or previous stroke. Consequently, in patients with first-ever AIS and intrathecal IgG synthesis, physicians should search for concomitant inflammatory CNS disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0283476","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:07:47Z","timestamp":1680286067000},"page":"e0283476","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8722-4255","authenticated-orcid":true,"given":"Kornelia","family":"Laichinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"D\u00fcnschede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9900-4295","authenticated-orcid":true,"given":"Christoph","family":"Ruschil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Feil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-3615","authenticated-orcid":true,"given":"Ulf","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kowarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-3020","authenticated-orcid":true,"given":"Annerose","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"2","key":"pone.0283476.ref001","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12017-009-8074-1","article-title":"Leukocyte recruitment and ischemic brain injury","volume":"12","author":"G Yilmaz","year":"2010","journal-title":"Neuromolecular Med"},{"issue":"6","key":"pone.0283476.ref002","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential","volume":"130","author":"C Iadecola","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"pone.0283476.ref003","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.31.5.590","article-title":"Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease","volume":"31","author":"B Rostrom","year":"1981","journal-title":"Neurology"},{"issue":"3","key":"pone.0283476.ref004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/WNL.36.3.395","article-title":"Oligoclonal immunoglobulin G in acute subarachnoid hemorrhage and stroke","volume":"36","author":"SA Tsementzis","year":"1986","journal-title":"Neurology"},{"issue":"6","key":"pone.0283476.ref005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archneurol.2011.3252","article-title":"Evidence of Intrathecal Immunoglobulin Synthesis in Stroke","volume":"69","author":"H Pr\u00fcss","year":"2012","journal-title":"ARCH NEUROL"},{"key":"pone.0283476.ref006","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7197\/cmj.v36i4.5000071471","article-title":"The relationship of intrathecal immunoglobulin levels with clinic symptoms and prognosis for acute phase ischemic stroke patients","volume":"36","author":"A Bolay\u0131r","year":"2014","journal-title":"Cumhuriyet Med J"},{"issue":"3","key":"pone.0283476.ref007","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/nf-2018-0031","article-title":"Friend or foe?\u2013B cells in stroke","volume":"25","author":"D Berchtold","year":"2019","journal-title":"Neuroforum"},{"issue":"5","key":"pone.0283476.ref008","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1523\/JNEUROSCI.4098-14.2015","article-title":"B-lymphocyte-mediated delayed cognitive impairment following stroke","volume":"35","author":"KP Doyle","year":"2015","journal-title":"J Neurosci"},{"issue":"23","key":"pone.0283476.ref009","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1523\/JNEUROSCI.1623-11.2011","article-title":"Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke","volume":"31","author":"X Ren","year":"2011","journal-title":"J Neurosci"},{"issue":"2","key":"pone.0283476.ref010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-014-1355-2","article-title":"Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke.","volume":"129","author":"J Neumann","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0283476.ref011","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11011-013-9474-3","article-title":"Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice.","volume":"29","author":"S Bodhankar","year":"2014","journal-title":"Metab Brain Dis."},{"key":"pone.0283476.ref012","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fimmu.2019.00686","article-title":"Autoimmunity After Ischemic Stroke and Brain Injury.","volume":"10","author":"E Javidi","year":"2019","journal-title":"Front Immunol"},{"issue":"106","key":"pone.0283476.ref013","first-page":"381","article-title":"Stroke induces a rapid adaptive autoimmune response to novel neuronal antigens","volume":"19","author":"SB Ortega","year":"2015","journal-title":"Discov Med"},{"key":"pone.0283476.ref014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"MC Kowarik","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"1","key":"pone.0283476.ref015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-019-1601-6","article-title":"Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases","volume":"16","author":"G Lepennetier","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"8","key":"pone.0283476.ref016","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"M Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"pone.0283476.ref017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"HP Adams","year":"1993","journal-title":"Stroke"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:08:00Z","timestamp":1680286080000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283476"}},"subtitle":[],"editor":[{"given":"Tommaso","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0283476","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}